Alnylam Pharmaceuticals
Cambridge, Massachusetts, United States
1,001-5,000 Employees
Healthcare
•Tech
SVP, Clinical Research
Cambridge
About this role
The full description for this role lives on Alnylam Pharmaceuticals's careers site. Request a referral below to get your application in front of the team, or view the original posting for the complete details.
View original postingAbout Alnylam Pharmaceuticals
Alnylam Pharmaceuticals (NASDAQ: ALNY) is a biopharmaceutical company founded in 2002, focused on developing RNA interference (RNAi) therapeutics for a wide range of diseases. The company's innovative approach to gene silencing has the potential to revolutionize the treatment of genetic and rare diseases, providing new hope for patients worldwide.
Alnylam is committed to advancing cutting-edge science and delivering transformative therapies to improve the lives of those in need.
Financials
Type
public
Annual Revenue
--
Market Cap
$37.6B+
Subscribe to Refer Me premium to get referred to this role at Alnylam Pharmaceuticals!
